This information was published on 2025-01-07T09:43:47 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2399459 |
| (220) |
20 Oct 2023
|
| (300) |
US, 26 Apr 2023, 97908992
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutics and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product, namely, antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of Immunoglobulin Y antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments |
| (540) | PRODIGY BIOTECH |
| (550) | Word |
| (730) |
Prodigy Biotech, Inc.
|
| (750) |
Henry Hughes IP Ltd
|
Find out more about publications on the About page.